Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.1 | - |
NAV | ₹12.20 | - |
Fund Started | 16 Oct 2023 | - |
Fund Size | ₹99.43 Cr | - |
Exit Load | Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 365 days. | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 18.45% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 83.15% | - |
Cash | 16.85% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Supriya Lifescience Ltd. | 3.56% |
Eris Lifesciences Ltd. | 3.20% |
Karur Vysya Bank Ltd. | 2.94% |
Crompton Greaves Consumer Electricals Ltd. | 2.63% |
EPL Ltd. | 2.56% |
ICICI Prudential Life Insurance Company Ltd. | 2.48% |
MPS Ltd. | 2.46% |
CMS Info Systems Ltd. | 2.39% |
CCL Products (India) Ltd. | 2.37% |
HDFC Bank Ltd. | 2.35% |
Name | Chirag Mehta | - |
Start Date | 16 Oct 2023 | - |
Name
Start Date
Description | The Scheme seeks to generate capital appreciation by investing predominantly in Small Cap Stocks. There is no assurance that the investment objective of the scheme will be achieved. | - |
Launch Date | 16 Oct 2023 | - |
Description
Launch Date